Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open on the non-farm payrolls print that blew away estimates, despite a significant de
Pfizer: A Great Opportunity Post Earnings
06:08pm, Wednesday, 11'th Feb 2026
Pfizer remains a Strong Buy, offering compelling value with a 6.32% dividend yield and a P/E Non-GAAP of 8.43. PFE's non-COVID portfolio posted 6% operational growth in 2025, with international market
2 Urgent Sells And 2 No Brainer Dividend Buys
04:06pm, Wednesday, 11'th Feb 2026
One thing I've learned is the pendulum always swings. It is in our best approach to sell high and buy low. This has worked well for us, as our returns suggest.
Is Now the Best Time to Buy Pfizer Stock?
01:48pm, Wednesday, 11'th Feb 2026
Pfizer continues to lag the market due to poor financial results and upcoming challenges. However, the company is entering an important period in its clinical development.
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip.
10:15am, Wednesday, 11'th Feb 2026
Eli Lilly is priced for perfection thanks to its GLP-1 drugs, while Wall Street seems to have forgotten about these two high-yield healthcare stocks.
Ultra-High Yield Dividend Stocks Yielding More Than 5%
10:00am, Wednesday, 11'th Feb 2026
Choosing the right investment vehicles can ensure steady income and wealth generation.
Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff?
09:11am, Wednesday, 11'th Feb 2026
PFE bets on new and acquired drugs to reignite growth as COVID sales fade and a 2026-2030 patent cliff threatens key blockbusters.
Is Pfizer Stock Now A Value Trap?
08:56am, Wednesday, 11'th Feb 2026
Pfizer (PFE) is confronting challenges. Even the most prominent companies are not beyond reach.
Pfizer Inc. $PFE Shares Bought by Advisors Asset Management Inc.
03:34am, Wednesday, 11'th Feb 2026
Advisors Asset Management Inc. lifted its stake in shares of Pfizer Inc. (NYSE: PFE) by 4.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissi
Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund
03:20pm, Tuesday, 10'th Feb 2026
Pfizer agreed to accept $29 million to resolve a dispute with the U.S. Securities and Exchange Commission stemming from the regulator's 2013 insider trading settlement with billionaire Steven A. Cohen
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 10'th Feb 2026
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
SVB Wealth LLC Reduces Stock Position in Pfizer Inc. $PFE
03:50am, Tuesday, 10'th Feb 2026
SVB Wealth LLC lowered its stake in shares of Pfizer Inc. (NYSE: PFE) by 14.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 143,238 shares of the
Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend?
01:00pm, Monday, 09'th Feb 2026
Pfizer recently reported earnings, which weren't terribly impressive. Concerns about its future growth have weighed on its valuation in recent years.
Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4?
10:17am, Monday, 09'th Feb 2026
PFE beat Q4 estimates, but weak COVID sales and soft 2026 guidance kept shares muted as investors weigh pipeline strength against looming headwinds.
Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones
08:50am, Monday, 09'th Feb 2026
New Chairman Joins Entera's Board with Senior Global Leadership Experience from Pfizer, Wyeth and Other Leading Biopharma Companies as Entera Advances Multiple Oral Peptide Programs Toward Significant
